J.L. Coenen

407 total citations
17 papers, 178 citations indexed

About

J.L. Coenen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology. According to data from OpenAlex, J.L. Coenen has authored 17 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in J.L. Coenen's work include Prostate Cancer Treatment and Research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). J.L. Coenen is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). J.L. Coenen collaborates with scholars based in Netherlands, Norway and United States. J.L. Coenen's co-authors include Cees Th.B.M. van Deursen, P. J. Brombacher, Jos van Pelt, J. W. J. van Wersch, M. Fickers, Winald R. Gerritsen, Ronald de Wit, P.C. de Jong, Erik van Werkhoven and Albert J. ten Tije and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Chemistry and European Journal of Cancer.

In The Last Decade

J.L. Coenen

16 papers receiving 176 citations

Peers

Countries citing papers authored by J.L. Coenen

Since Specialization

Citations

This map shows the geographic impact of J.L. Coenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Coenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Coenen more than expected).

Fields of papers citing papers by J.L. Coenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Coenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Coenen. The network helps show where J.L. Coenen may publish in the future.

Co-authorship network of co-authors of J.L. Coenen

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Coenen. A scholar is included among the top collaborators of J.L. Coenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Coenen. J.L. Coenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial 2022 ·The Lancet Haematology ·Nick de Jonge, Jonne J. Sikkens, Sonja Zweegman, Aart Beeker, (unknown), A H E Herbers, (unknown), (unknown), J.L. Coenen, Birgit I. Lissenberg‐Witte, Mark H.H. Kramer, Michiel A. van Agtmael, Jeroen J. W. M. Janssen	20
2	The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population 2021 ·Prostate Cancer and Prostatic Diseases ·Hans M. Westgeest, (unknown), Alfons J.M. van den Eertwegh, Ronald de Wit, Andries M. Bergman, R. Jeroen A. van Moorselaar, J.L. Coenen, (unknown), Diederik M. Somford, Niven Mehra, Inge M. van Oort, Katja K.H. Aben, Winald R. Gerritsen, Carin A. Uyl‐de Groot	9
3	PCN330 A COMPARISON OF HEALTHCARE AND SOCIETAL COSTS OF HOSPITAL-BASED AND HOME-BASED SUBCUTANEOUS INJECTIONS OF TRASTUZUMAB 2019 ·Value in Health ·M Franken, Tim A. Kanters, J.L. Coenen, Paul de Jong, Agnes Jager, C.A. Uyl-de Groot	1
4	Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands 2019 ·Clinical Genitourinary Cancer ·Hans M. Westgeest, (unknown), (unknown), Ronald de Wit, J.L. Coenen, H. Pieter van den Berg, Niven Mehra, Inge M. van Oort, L. Fossion, Mathijs P. Hendriks, Haiko J. Bloemendal, Addy C.M. van de Luijtgaarden, Daan ten Bokkel Huinink, (unknown), (unknown), Marco B. Polée, Nir I. Weijl, Andries M. Bergman, Carin A. Uyl‐de Groot, Winald R. Gerritsen	5
5	PCN85 - SAVING HEALTHCARE AND SOCIETAL COSTS BY CHANGING THE ROUTE OF ADMINISTRATION OF ONCOLOGY DRUGS 2018 ·Value in Health ·M Franken, Tim A. Kanters, J.L. Coenen, Paul de Jong, (unknown), Pieternella J. Lugtenburg, (unknown), C.A. Uyl-de Groot	2
6	Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry 2018 ·European Urology Supplements ·(unknown), (unknown), (unknown), Jeroen van Moorselaar, Niven Mehra, J.L. Coenen, F. van den Bergh, Katja K.H. Aben, Andries M. Bergman, Diederik M. Somford, Jules Lavalaye, Carin A. Uyl‐de Groot, Winald R. Gerritsen	1
7	A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial 2017 ·European Journal of Cancer ·(unknown), H. Pieter van den Berg, Linda de Munck, Aart Beeker, Carolien H. Smorenburg, Walter L. Vervenne, J.L. Coenen, Henk M.W. Verheul, Winald R. Gerritsen, Alfons J.M. van den Eertwegh	18
8	A retrospective study on cabazitaxel and abiraterone acetate sequential treatment (CAST) in docetaxel treated metastatic castrate-resistant prostate cancer patients 2013 ·European Journal of Cancer ·(unknown), J.L. Coenen, Peter van den Berg, Inge M. van Oort, Ronald de Wit, Andries M. Bergman, (unknown), Paul Hamberg, Hans Gelderblom	4
9	Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro) 2012 ·European Journal of Cancer ·Hielke J. Meulenbeld, Erik van Werkhoven, J.L. Coenen, G.J. Creemers, O. J. L. Loosveld, P.C. de Jong, Albert J. ten Tije, Sophie D. Fosså, M. Polée, Winald R. Gerritsen, Otilia Dalesio, Ronald de Wit	31
10	Randomized phase III study of docetaxel with or without risedronate in patients with bone metastases from castration-resistant prostate cancer (CRPC): The Netherlands Prostate Study (NePro). 2011 ·Journal of Clinical Oncology ·Hielke J. Meulenbeld, Erik van Werkhoven, J.L. Coenen, Geert‐Jan Creemers, O. J. L. Loosveld, P.C. de Jong, Albert J. ten Tije, Sophie D. Fosså, M. Polée, Winald R. Gerritsen, Otilia Dalesio, Ronald de Wit	3
11	Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience 2010 ·Bone Marrow Transplantation ·Monique C. Minnema, Suzanne van Dorp, Niels W.C.J. van de Donk, (unknown), Marie José Kersten, J.L. Coenen, Harry C. Schouten, Sonja Zweegman, Ron Schaafsma, H M Lokhorst	6
12	A288 Non-Myeloablative Allo-SCT for Relapsed Myeloma: A Single-Center Experience 2009 ·Clinical Lymphoma & Myeloma ·(unknown), Suzanne van Dorp, Niels W.C.J. van de Donk, (unknown), (unknown), J.L. Coenen, Harry C. Schouten, Sonja Zweegman, Ron Schaafsma, HM Lokhorst	0
13	Extrapulmonary lymphangioleiomyomatosis: an unusual cause of biliary tract obstruction. 2008 ·PubMed ·(unknown), Joshua A. Vecht, Helen Bergen, J.L. Coenen	3
14	Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC) 2005 ·Journal of Clinical Oncology ·(unknown), P.C.M. Pasker-de Jong, Robert S. de Jong, A.H. Honkoop, J.L. Coenen, C. J. Rodenburg, (unknown), J. Douma	3
15	A breakthrough in cryosurgery 2002 ·Surgical Endoscopy ·Maaike A. Sikma, J.L. Coenen, (unknown), Boudewijn A.A.M. van Hasselt, (unknown)	2
16	Quantitative Determination of Non-Haem Iron and Ferritin Iron in Bone Marrow Using Flameless Atomic Absorption Spectrophotometry. A Comparative Study on the Cytological and Chemical Determination of the Bone Marrow Iron Content 1991 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Marja P. van Dieijen‐Visser, (unknown), J.L. Coenen, P. J. Brombacher	1
17	Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease 1991 ·Clinical Chemistry ·J.L. Coenen, (unknown), Jos van Pelt, Cees Th.B.M. van Deursen, M. Fickers, J. W. J. van Wersch, P. J. Brombacher	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact